https://retractionwatch.com/2022/10/07/paper-by-gene-therapy-zolgensma-developer-retracted-because-of-discrepancies-in-mouse-survival-rates/
0
0
10/7/22 at 10:02pm
Organization
Retractionwatch.com
47 words
0
Comments
Bryan Kaspar A paper describing preclinical work on what appears to be the gene therapy for spinal muscular atrophy now sold as Zolgensma has been retracted for data inaccuracies. The article…
You are the first to view
Create an account
or login to join the discussion